THE USE OF SELANK IN THE TREATMENT OF AUTONOMIC AND PSYCHOEMOTIONAL DISORDERS IN WOMEN WITH CLIMACTERIC SYNDROME

DOI: https://doi.org/10.29296/25877305-2019-12-13
Download full text PDF
Issue: 
12
Year: 
2019

P. Starikov(1, 2), Candidate of Medical Sciences, Professor V. Fedorov(3), MD 1-Yaroslav the Wise Novgorod State University, Veliky Novgorod 2-Central City Clinical Hospital, Veliky Novgorod 3-Yaroslavl State Medical University

The role of Selank in the therapy of autonomic and psychoemotional disorders was studied in women with climacteric syndrome.
Keywords: 
eurology
therapy
women’s health
climacteric syndrome
psychoemotional disorders
Selank

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Andreeva L.A., Alfeeva L.Ju., Grivennikov I.A. i dr. Anksioliticheskoe sredstvo i farmatsevticheskaja kompozitsija anksioliticheskogo dejstvija. Patent Rossijskoj Federatsii №2155065, 2000 [Andreeva L.A., Alfeeva L.Yu., Grivennikov I.A. et al. Anksioliticheskoe sredstvo i farmatsevticheskaya kompozitsiya anksioliticheskogo deistviya. Patent Rossiiskoi Federatsii №2155065, 2000 (in Russ.)].
  2. Baranov I.I., Serov V.N. Klimaktoplan v terapii klimaktericheskogo sindroma // RMZh. – 2005; 1: 11–4 [Baranov I.I., Serov V.N. Klimaktoplan v terapii klimaktericheskogo sindroma // RMZh. – 2005; 1: 11–4 (in Russ.)].
  3. Gavisova A.A., Tverdikova M.A., Balushkina A.A. Klimaktericheskij sindrom: osobennosti terapii psihoemotsional'nyh narushenij // RMZh. – 2009; 20: 1408–11 [Gavisova A.A., Tverdikova M.A., Balushkina A.A. Klimaktericheskii sindrom: osobennosti terapii psikhoemotsional’nykh narushenii // RMZh. – 2009; 20: 1408–11 (in Russ.)].
  4. Gur'eva V.A., Karacheva Ju.O. Effektivnost' ozonoterapii i preparata tsimitsifugi pri sochetannoj patologii: distsirkuljatornoj entsefalopatii I–II stadii i klimaktericheskom sindrome legkoj stepeni tjazhesti // RMZh. – 2010; 19: 1179 [Gur’eva V.A., Karacheva Yu.O. Effektivnost’ ozonoterapii i preparata tsimitsifugi pri sochetannoi patologii: distsirkulyatornoi entsefalopatii I–II stadii i klimaktericheskom sindrome legkoi stepeni tyazhesti // RMZh. – 2010; 19: 1179 (in Russ.)].
  5. Dikevich E.A. Nekotorye voprosy korrektsii psihoemotsional'nyh rasstrojstv, svjazannyh s klimaksom // RMZh. – 2007; 28: 2186 [Dikevich E.A. Nekotorye voprosy korrektsii psikhoemotsional’nykh rasstroistv, svyazannykh s klimaksom // RMZh. – 2007; 28: 2186 (in Russ.)].
  6. Dikevich E.A., Ovinnikova T.E. Terapija depressivnyh rasstrojstv, svjazannyh s perimenopauzoj // RMZh. – 2008; 12: 1720–3 [Dikevich E.A., Ovinnikova T.E. Terapiya depressivnykh rasstroistv, svyazannykh s perimenopauzoi // RMZh. – 2008; 12: 1720–3 (in Russ.)].
  7. Zozulja A.A., Kost N.V., Sokolov O.Ju. i dr. Ingibirujuschij effekt Selanka na aktivnost' enkefalindegradirujuschih fermentov kak odin iz vozmozhnyh mehanizmov ego anksioliticheskogo dejstvija // Bjul. eksp. biol. med. – 2001; 131 (4): 376–8 [Zozulya A.A., Kost N.V., Sokolov O.Yu. et al. Ingibiruyushchii effekt selanka na aktivnost’ enkefalindegradiruyushchikh fermentov kak odin iz vozmozhnykh mekhanizmov ego anksioliticheskogo deistviya // Byul. eksp. biol. med. – 2001; 131 (4): 376–8 (in Russ.)].
  8. Zozulja A.A., Neznamov G.G., Sjunjakov T.S. i dr. Effektivnost' i vozmozhnye mehanizmy dejstvija novogo peptidnogo anksiolitika Selanka pri terapii generalizovannogo trevozhnogo rasstrojstva i nevrastenii // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2008; 108 (4): 38–49 [Zozulya A.A., Neznamov G.G., Syunyakov T.S. et al. Effektivnost’ i vozmozhnye mekhanizmy deistviya novogo peptidnogo anksiolitika Selanka pri terapii generalizovannogo trevozhnogo rasstroistva i nevrastenii // Zhurn. nevrol. i psikhiat. im. S.S. Korsakova. – 2008; 108 (4): 38–49 (in Russ.)].
  9. Zolotarev Ju.A., Dadajan A.K., Dolotov O.V. i dr. Ravnomerno mechennye tritiem peptidy v issledovanijah po ih degradatsii in vivo i in vitro // Bioorganicheskaja himija. – 2006; 32 (2): 80–8 [Zolotarev Yu.A., Dadayan A.K., Dolotov O.V. et al. Evenly Tritium-Labeled Peptides in Study of Peptide In Vivo and In Vitro Biodegradation // Bioorganicheskaya khimiya. – 2006; 32 (2): 80–8 (in Russ.)].
  10. Kozlovskaja M.M., Neznamov G.G., Koshelev V.V. i dr. Rezul'taty kliniko-farmakologicheskogo issledovanija peptidnogo preparata Selank v kachestve anksioliticheskogo sredstva // Sots. i klin. psihiatrija. – 2003; 4: 28–36 [Kozlovskaya M.M., Neznamov G.G., Koshelev V.V. et al. Rezul’taty kliniko-farmakologicheskogo issledovaniya peptidnogo preparata Selank v kachestve anksioliticheskogo sredstva // Sots. i klin. psikhiatriya. – 2003; 4: 28–36 (in Russ.)].
  11. Kost N.V. Opioidergicheskie mehanizmy trevozhnyh rasstrojstv i effektov anksioliticheskih preparatov. Avtoref. diss. … d-ra med. nauk. M., 2007; 49 s. [Kost N.V. Opioidergicheskie mekhanizmy trevozhnykh rasstroistv i effektov anksioliticheskikh preparatov. Avtoref. diss. … d-ra med. nauk. M., 2007; 49 s. (in Russ.)].
  12. Kulakov V.I., Smetnik V.P. Rukovodstvo po klimakteriju / M., 2001; 685 s. [Kulakov V.I., Smetnik V.P. Rukovodstvo po klimakteriyu / M., 2001; 685 s. (in Russ.)].
  13. Lobachev L.S. Dinamicheskie tendentsii depressivnyh rasstrojstv. Mat-ly I Nauchno-prakt. konf. psihiatrov i narkologov. Rostov-na-Donu, 2004; s. 239–95; 29–31 [Lobachev L.S. Dinamicheskie tendentsii depressivnykh rasstroistv. Mat-ly I nauchno-prakt. konf. psikhiatrov i narkologov. Rostov-na-Donu, 2004; s. 239–95; 29–31 (in Russ.)].
  14. Manusharova R.A., Cherkezova E.I. Sovremennye vozmozhnosti diagnostiki i lechenija klimaktericheskogo sindroma // RMZh. – 2008; 25: 1712 [Manusharova R.A., Cherkezova E.I. Sovremennye vozmozhnosti diagnostiki i lecheniya klimaktericheskogo sindroma // RMZh. – 2008; 25: 1712 (in Russ.)].
  15. Mjasoedov N.F., Illarioshkin S.N., Zhuravleva E.Ju. i dr. Peptidnaja nejroprotektsija preparatom «Selank, kapli nazal'nye 0,15%» u patsientov na rannej stadii s bolezn'ju Parkinsona // Vestn. nevrologii, psihiatrii i nejrohirurgii. – 2013; 6: 86–95 [Myasoedov N.F., Illarioshkin S.N., Zhuravleva E.Y. et al. Peptide preparation neuroprotection «Selank – 0,15 % a nasal drop solution» patients with parkinson’’s disease at an early stage // Vestn. nevrologii, psikhiatrii i neirokhirurgii. – 2013; 6: 86–95 (in Russ.)].
  16. Neznamov G.G., Sjunjakov T.S. i dr. Rezul'taty kliniko-farmakologicheskogo issledovanija nootropnyh svojstv Selanka – novogo anksiolitika peptidnoj prirody // Psihiatrija. – 2010; 4: 26–35 [Neznamov G.G., Syunyakov T.S. et al. Rezul’taty kliniko-farmakologicheskogo issledovaniya nootropnykh svoistv Selanka – novogo anksiolitika peptidnoi prirody // Psikhiatriya. – 2010; 4: 26–35 (in Russ.)].
  17. Repina M.A. Problemy menopauzal'nogo perehoda: nizkodozirovannaja zamestitel'naja gormonal'naja terapija mikronizirovannym estradiolom v sochetanii s didrogesteronom // Farmateka. – 2008; 14: 39–44 [Repina M.A. Problemy menopauzal’nogo perekhoda: nizkodozirovannaya zamestitel’naya gormonal’naya terapiya mikronizirovannym estradiolom v sochetanii s didrogesteronom // Farmateka. – 2008; 14: 39–44 (in Russ.)].
  18. Saidova R.A., Aleksanjan S.G., Tropynina E.V. Sovremennye printsipy gormonal'noj korrektsii narushenij menstrual'noj funktsii v perimenopauzal'nom periode // Voprosy ginekologii, akusherstva i perinatologii. – 2008; 4: 46–52 [Saidova R.A., Aleksanyan S.G., Tropynina E.V. Modern principles of hormonal correction of menstrual disorders in perimenopause // Voprosy ginekologii, akusherstva i perinatologii. – 2008; 4: 46–52 (in Russ.)].
  19. Cmetnik V.P. Meditsina klimakterija / Jaroslavl': OOO «Izdatel'stvo Litera», 2006; 848 s. [Smetnik V.P. Meditsina klimakteriya / Yaroslavl’: OOO «Izdatel’stvo Litera», 2006; 848 s. (in Russ.)].
  20. Sjunjakov T.S. Kliniko-farmakologicheskaja harakteristika anksioliticheskogo dejstvija novogo peptidnogo preparata selank. Avtoref. diss. … kand. Med. Nauk. M., 2010; 24 s. [Syunyakov T.S. Kliniko-farmakologicheskaya kharakteristika anksioliticheskogo deistviya novogo peptidnogo preparata selank. Avtoref. diss. … kand. Med. Nauk. M., 2010; 24 s. (in Russ.)].
  21. Schnatz P., Banever A., Greene J. Menopausal symptoms in clinical population: a pilot study // Menopause. – 2005; 12 (5): 623–9.